Dexpramipexole

CAS No. 104632-28-2

Dexpramipexole( R)-Pramipexole | KNS-760704 )

Catalog No. M10230 CAS No. 104632-28-2

A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 42 In Stock
10MG 69 In Stock
25MG 140 In Stock
50MG 212 In Stock
100MG 303 In Stock
200MG 452 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dexpramipexole
  • Note
    Research use only, not for human use.
  • Brief Description
    A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.
  • Description
    A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively; also possesses low/insignificant affinity (500–10,000 nM) for the 5-HT1A, 5-HT1B, 5-HT1D, and α2-adrenergic receptors; used for treating Parkinson's disease (PD) and restless legs syndrome (RLS).Alzheimer's Disease Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    R)-Pramipexole | KNS-760704
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine Receptor
  • Research Area
    Neurological Disease
  • Indication
    Alzheimer Disease

Chemical Information

  • CAS Number
    104632-28-2
  • Formula Weight
    211.3271
  • Molecular Formula
    C10H17N3S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CCCNC1CCC2=C(C1)SC(=N2)N
  • Chemical Name
    2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (6R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Alavian KN, et al. Brain Res. 2012 Mar 29;1446:1-11. 2. Cudkowicz M, et al. Nat Med. 2011 Nov 20;17(12):1652-6. 3. Bozik ME, et al. J Clin Pharmacol. 2011 Aug;51(8):1177-85.
molnova catalog
related products
  • NMI 8739

    NMI 8739 is an agonist of D2 autoreceptor. NMI 8739 reduces NO production and elicits concentration-dependent suppression of CCL-20, MCP-1 and IL-6 release.

  • E6446

    E6446 inhibits Toll-like receptor (TLR)7 and 9 signaling. E6446 works in a variety of human and mouse cell types and inhibits DNA-TLR9 interaction in vitro.

  • Rotigotine hydrochlo...

    A non-selective agonist of the dopamine D3 receptor (Ki=0.71 nM); has 10-fold selectivity for the D3 receptor over the D2, D4, and D5 receptors and 100-fold selectivity for the D3 receptor over the D1 receptor.